Free Trial

Kellanova (K) Financials

Kellanova logo
$80.06 -0.02 (-0.02%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$79.46 -0.60 (-0.75%)
As of 08/8/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Kellanova

Annual Income Statements for Kellanova

This table shows Kellanova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024
Net Income / (Loss) Attributable to Common Shareholders
632 614 699 1,254 1,336 960 1,251 1,481 958 951 1,330
Consolidated Net Income / (Loss)
633 614 700 1,254 1,344 977 1,264 1,488 960 964 1,343
Net Income / (Loss) Continuing Operations
633 614 700 1,254 1,148 977 1,264 1,103 731 788 1,356
Total Pre-Tax Income
825 773 934 1,657 1,329 1,305 1,601 1,452 902 1,040 1,654
Total Operating Income
1,024 1,091 1,483 1,387 1,706 1,401 1,761 1,383 1,211 1,505 1,873
Total Gross Profit
5,063 4,681 4,834 4,699 4,726 4,381 4,727 3,818 3,811 4,283 4,545
Total Revenue
14,580 13,525 12,965 12,854 13,547 13,578 13,770 11,747 12,653 13,122 12,749
Operating Revenue
14,580 13,525 12,965 12,854 13,547 13,578 13,770 11,747 12,653 13,122 12,749
Total Cost of Revenue
9,517 8,844 8,131 8,155 8,821 9,197 9,043 7,929 8,842 8,839 8,204
Operating Cost of Revenue
9,517 8,844 8,131 8,155 8,821 9,197 9,043 7,929 8,842 8,839 8,204
Total Operating Expenses
4,039 3,590 3,351 3,312 3,020 2,980 2,966 2,435 2,600 2,778 2,672
Selling, General & Admin Expense
4,039 3,590 3,351 3,312 3,020 2,980 2,966 2,435 2,600 2,778 2,672
Total Other Income / (Expense), net
-199 -318 -549 270 -377 -96 -160 72 -300 -465 -213
Interest Expense
209 227 406 256 287 284 281 205 201 303 311
Interest & Investment Income
- - - - - - - 3.00 9.00 - 6.00
Other Income / (Expense), net
10 -91 -143 526 -90 188 121 274 -108 -162 92
Income Tax Expense
186 159 235 410 181 321 323 353 180 258 304
Net Income / (Loss) Discontinued Operations
- - - - - - - 392 231 176 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
1.00 0.00 1.00 0.00 8.00 17 13 7.00 2.00 13 13
Basic Earnings per Share
$1.76 $1.74 $1.99 $3.61 $3.85 $2.81 $3.65 $8.72 $5.62 $2.78 $7.84
Weighted Average Basic Shares Outstanding
358M 354M 350M 347.40M 347M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Diluted Earnings per Share
$1.75 $1.72 $1.97 $3.58 $3.83 $2.80 $3.63 $8.66 $5.58 $2.76 $7.76
Weighted Average Diluted Shares Outstanding
358M 354M 350M 347.40M 347M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Weighted Average Basic & Diluted Shares Outstanding
358M 354M 350M 347.40M 347M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Cash Dividends to Common per Share
$1.90 $1.98 $2.04 $2.12 $2.20 $2.26 $2.28 $2.31 $2.34 $2.34 $2.26

Quarterly Income Statements for Kellanova

This table shows Kellanova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Net Income / (Loss) Attributable to Common Shareholders
-100 298 352 268 33 267 341 364 358 304 299
Consolidated Net Income / (Loss)
-102 302 357 269 36 271 344 367 361 308 303
Net Income / (Loss) Continuing Operations
-331 234 298 198 58 271 347 370 368 308 303
Total Pre-Tax Income
-437 293 372 277 98 353 443 402 456 378 384
Total Operating Income
-89 346 417 414 328 393 493 456 531 430 438
Total Gross Profit
356 984 1,094 1,110 1,095 1,031 1,161 1,176 1,177 1,059 1,090
Total Revenue
1,171 3,342 3,351 3,255 3,174 3,200 3,192 3,233 3,124 3,083 3,203
Operating Revenue
1,171 3,342 3,351 3,255 3,174 3,200 3,192 3,233 3,124 3,083 3,203
Total Cost of Revenue
815 2,358 2,257 2,145 2,079 2,169 2,031 2,057 1,947 2,024 2,113
Operating Cost of Revenue
815 2,358 2,257 2,145 2,079 2,169 2,031 2,057 1,947 2,024 2,113
Total Operating Expenses
445 638 677 696 767 638 668 720 646 629 652
Selling, General & Admin Expense
445 638 677 696 767 638 668 720 646 629 652
Total Other Income / (Expense), net
-339 -53 -42 -138 -232 -40 -49 -52 -72 -52 -54
Interest Expense
52 70 73 75 85 83 83 75 70 63 63
Other Income / (Expense), net
-296 17 28 -62 -145 43 33 21 -5.00 11 9.00
Income Tax Expense
-103 61 77 78 42 82 97 34 91 73 83
Other Gains / (Losses), net
- 2.00 - - - 0.00 - - - 3.00 2.00
Net Income / (Loss) Discontinued Operations
- 68 64 72 -28 0.00 0.00 0.00 - 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-2.00 4.00 5.00 1.00 3.00 4.00 3.00 3.00 3.00 4.00 4.00
Basic Earnings per Share
$2.51 $0.87 $2.08 $1.58 ($1.75) $0.78 $1.01 $2.14 $2.90 $0.88 $0.86
Weighted Average Basic Shares Outstanding
341.83M 342M 343M 342M 340.68M 341M 342M 343M 345.22M 346M 347M
Diluted Earnings per Share
$2.50 $0.86 $2.06 $1.56 ($1.72) $0.78 $1.00 $2.10 $2.88 $0.87 $0.85
Weighted Average Diluted Shares Outstanding
341.83M 345M 345M 345M 340.68M 344M 345M 347M 345.22M 349M 350M
Weighted Average Basic & Diluted Shares Outstanding
341.83M 342.76M 342.35M 342.52M 340.68M 341.88M 342.29M 344.70M 345.22M 346.94M 347.67M
Cash Dividends to Common per Share
$0.59 $0.59 $0.59 $0.60 $0.56 $0.56 $0.56 $0.57 $0.57 - $0.57

Annual Cash Flow Statements for Kellanova

This table details how cash moves in and out of Kellanova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024
Net Change in Cash & Equivalents
170 -192 29 1.00 40 76 38 -149 13 -25 420
Net Cash From Operating Activities
1,793 1,691 1,271 403 1,536 1,176 1,986 1,701 1,651 1,645 1,760
Net Cash From Continuing Operating Activities
2,043 1,675 1,107 403 1,536 1,176 1,986 1,701 1,651 1,645 1,760
Net Income / (Loss) Continuing Operations
633 614 700 1,254 1,344 977 1,264 1,495 962 964 1,356
Consolidated Net Income / (Loss)
633 614 700 1,254 1,344 977 1,264 1,495 962 964 1,356
Depreciation Expense
503 534 517 481 516 484 479 467 478 419 367
Non-Cash Adjustments To Reconcile Net Income
891 457 217 -234 -321 -220 -54 -388 271 259 194
Changes in Operating Assets and Liabilities, net
16 70 -327 -1,098 -3.00 -65 297 127 -60 3.00 -157
Net Cash From Investing Activities
-573 -1,127 -392 149 -948 774 -585 -528 -448 -562 -750
Net Cash From Continuing Investing Activities
-573 -1,127 -392 149 -948 774 -585 -528 -448 -562 -750
Purchase of Property, Plant & Equipment
-582 -553 -507 -501 -578 -586 -505 -553 -488 -677 -628
Acquisitions
-6.00 -617 -400 -592 -417 0.00 0.00 -10 0.00 0.00 0.00
Purchase of Investments
- 0.00 -2.00 -7.00 -8.00 -18 -331 -61 -17 53 -357
Divestitures
- - 27 0.00 0.00 1,332 0.00 0.00 0.00 0.00 0.00
Sale and/or Maturity of Investments
0.00 - - 0.00 0.00 83 269 91 56 64 209
Other Investing Activities, net
15 43 490 1,249 55 -37 -18 5.00 1.00 -2.00 26
Net Cash From Financing Activities
-1,063 -706 -786 -604 -566 -1,905 -1,388 -1,306 -1,081 -1,110 -607
Net Cash From Continuing Financing Activities
-1,063 -706 -786 -604 -566 -1,905 -1,388 -1,306 -1,081 -1,110 -607
Repayment of Debt
-2,075 -889 -4,630 -870 -706 -1,104 -1,303 -748 -665 -1,224 -663
Repurchase of Common Equity
-690 -731 -426 -516 -320 -220 0.00 -240 -300 -170 0.00
Payment of Dividends
-680 -700 -716 -736 -762 -769 -782 -788 -797 -800 -776
Issuance of Debt
2,165 1,353 4,618 1,421 1,055 124 585 407 404 1,102 619
Issuance of Common Equity
217 261 368 97 167 64 112 63 277 60 213
Other Financing Activities, net
- - - - 0.00 0.00 0.00 0.00 0.00 -78 0.00
Effect of Exchange Rate Changes
13 -50 -64 53 18 31 - -16 -109 2.00 17
Cash Interest Paid
209 228 405 258 280 284 249 213 220 291 303
Cash Income Taxes Paid
414 337 256 352 188 537 281 365 312 322 244

Quarterly Cash Flow Statements for Kellanova

This table details how cash moves in and out of Kellanova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Net Change in Cash & Equivalents
-74 48 -39 791 -825 -32 30 297 125 -364 24
Net Cash From Operating Activities
471 276 368 756 245 364 376 553 467 116 169
Net Cash From Continuing Operating Activities
471 276 368 756 245 364 376 553 467 116 169
Net Income / (Loss) Continuing Operations
-100 302 362 270 30 271 347 370 368 308 303
Consolidated Net Income / (Loss)
-100 302 362 270 30 271 347 370 368 308 303
Depreciation Expense
127 116 110 112 81 86 95 92 94 92 91
Non-Cash Adjustments To Reconcile Net Income
437 -8.00 -2.00 76 193 252 -16 -3.00 -39 -19 -119
Changes in Operating Assets and Liabilities, net
7.00 -134 -102 298 -59 -245 -50 94 44 -265 -106
Net Cash From Investing Activities
-136 -205 -139 -128 -90 -333 -121 -135 -161 -152 -170
Net Cash From Continuing Investing Activities
-136 -205 -139 -128 -90 -333 -121 -135 -161 -152 -170
Purchase of Property, Plant & Equipment
-138 -203 -136 -167 -171 -155 -142 -143 -188 -176 -148
Purchase of Investments
-39 12 -4.00 6.00 39 -182 -2.00 -124 -49 -72 -36
Sale and/or Maturity of Investments
42 5.00 5.00 5.00 49 0.00 13 132 64 84 14
Net Cash From Financing Activities
-416 -33 -266 179 -990 -58 -232 -127 -190 -313 32
Net Cash From Continuing Financing Activities
-416 -33 -266 179 -990 -58 -232 -127 -190 -313 32
Repayment of Debt
-652 -251 -30 -1.00 -942 110 -681 -75 -17 -158 184
Payment of Dividends
-201 -202 -202 -206 -190 -191 -192 -197 -196 -197 -198
Issuance of Common Equity
33 19 26 6.00 9.00 23 22 145 23 42 46
Effect of Exchange Rate Changes
7.00 10 -2.00 -16 10 -5.00 7.00 6.00 9.00 -15 -7.00

Annual Balance Sheets for Kellanova

This table presents Kellanova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024
Total Assets
15,153 15,251 15,111 16,351 17,780 17,564 17,996 18,178 18,496 15,621 15,628
Total Current Assets
3,340 3,236 2,940 3,036 3,157 3,431 3,482 3,394 4,186 3,330 3,754
Cash & Equivalents
443 251 280 281 321 397 435 286 299 274 694
Accounts Receivable
1,276 1,344 1,231 1,389 1,375 1,576 1,537 1,489 1,532 1,568 1,522
Inventories, net
1,279 1,250 1,238 1,217 1,330 1,226 1,284 1,398 1,339 1,243 1,165
Other Current Assets
342 391 191 149 131 232 226 221 378 245 373
Plant, Property, & Equipment, net
3,769 3,621 3,569 3,716 3,731 3,612 3,713 3,827 3,090 3,212 3,234
Total Noncurrent Assets
8,044 8,394 8,602 9,599 10,892 10,521 10,801 10,957 11,220 9,079 8,640
Long-Term Investments
1.00 456 438 429 413 404 391 424 432 184 99
Goodwill
4,971 4,968 5,166 5,504 6,050 5,861 5,799 5,771 5,381 5,160 5,003
Intangible Assets
2,295 2,268 2,369 2,639 3,361 2,576 2,491 2,409 2,239 1,930 1,760
Other Noncurrent Operating Assets
777 702 629 1,027 1,068 1,680 2,120 2,353 1,890 1,805 1,778
Total Liabilities & Shareholders' Equity
15,153 15,251 15,111 16,351 17,780 17,564 17,996 18,178 18,496 15,621 15,628
Total Liabilities
12,302 13,113 13,185 14,157 14,621 14,250 14,360 13,963 14,121 12,252 11,746
Total Current Liabilities
4,364 5,739 4,474 4,522 4,529 4,778 5,238 5,315 6,349 5,060 4,660
Short-Term Debt
1,435 2,470 1,069 779 686 727 729 849 1,247 784 745
Accounts Payable
1,528 1,907 2,014 2,269 2,427 2,387 2,471 2,573 2,568 2,314 2,236
Accrued Expenses
- - - - - 641 1,154 1,014 1,027 1,044 870
Other Current Liabilities
1,401 1,362 1,391 1,474 1,416 1,023 884 879 959 918 809
Total Noncurrent Liabilities
7,938 7,374 8,711 9,635 10,092 9,472 9,122 8,648 7,772 7,192 7,086
Long-Term Debt
5,935 5,275 6,698 7,836 8,207 7,195 6,746 6,262 5,317 5,089 4,998
Noncurrent Deferred & Payable Income Tax Liabilities
726 685 525 355 730 596 562 722 707 497 541
Noncurrent Employee Benefit Liabilities
777 946 1,024 839 651 705 769 706 593 613 599
Other Noncurrent Operating Liabilities
500 468 464 605 504 976 1,045 958 972 993 948
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,851 2,138 1,926 2,194 3,159 3,314 3,636 4,215 4,375 3,369 3,882
Total Preferred & Common Equity
2,789 2,128 1,910 2,178 2,601 2,747 3,112 3,720 3,941 3,175 3,775
Total Common Equity
2,789 2,128 1,910 2,178 2,601 2,747 3,112 3,720 3,941 3,175 3,775
Common Stock
783 850 911 983 1,000 1,026 1,077 1,128 1,173 1,206 1,226
Retained Earnings
6,689 6,597 6,571 7,069 7,652 7,859 8,326 9,028 9,197 8,804 9,358
Treasury Stock
-3,470 -3,943 -3,997 -4,417 -4,551 -4,690 -4,559 -4,715 -4,721 -4,794 -4,533
Accumulated Other Comprehensive Income / (Loss)
-1,213 -1,376 -1,575 -1,457 -1,500 -1,448 -1,732 -1,721 -1,708 -2,041 -2,276
Noncontrolling Interest
62 10 16 16 558 567 524 495 434 194 107

Quarterly Balance Sheets for Kellanova

This table presents Kellanova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Total Assets
18,496 18,630 18,101 18,695 15,621 15,315 15,299 15,763 15,628 15,474 15,871
Total Current Assets
4,186 4,324 4,288 4,986 3,330 3,450 3,470 3,855 3,754 3,474 3,673
Cash & Equivalents
299 347 308 1,099 274 242 272 569 694 330 354
Accounts Receivable
1,532 1,820 1,930 1,876 1,568 1,666 1,654 1,699 1,522 1,572 1,698
Inventories, net
1,339 1,801 1,706 1,632 1,243 1,210 1,185 1,219 1,165 1,223 1,256
Other Current Assets
378 356 344 379 245 332 359 368 373 349 365
Plant, Property, & Equipment, net
3,090 3,786 3,781 3,762 3,212 3,101 3,118 3,218 3,234 3,345 3,498
Total Noncurrent Assets
11,220 10,520 10,032 9,947 9,079 8,764 8,711 8,690 8,640 8,655 8,700
Long-Term Investments
432 434 323 194 184 100 107 101 99 103 108
Goodwill
5,381 5,690 5,517 5,496 5,160 5,067 5,043 5,045 5,003 5,020 5,060
Intangible Assets
2,239 2,297 2,091 2,065 1,930 1,828 1,804 1,799 1,760 1,774 1,814
Other Noncurrent Operating Assets
1,890 2,099 2,101 2,192 1,805 1,769 1,757 1,745 1,778 1,758 1,718
Total Liabilities & Shareholders' Equity
18,496 18,630 18,101 18,695 15,621 15,315 15,299 15,763 15,628 15,474 15,871
Total Liabilities
14,121 14,151 13,880 14,418 12,252 12,037 11,872 12,005 11,746 11,449 11,661
Total Current Liabilities
6,349 6,001 6,476 6,524 5,060 5,525 4,774 4,975 4,660 4,341 5,384
Short-Term Debt
1,247 1,038 1,660 1,546 784 1,539 856 802 745 590 1,538
Accounts Payable
2,568 2,900 2,810 2,789 2,314 2,209 2,267 2,368 2,236 2,129 2,205
Accrued Expenses
1,027 1,027 1,093 1,191 1,044 945 899 937 870 757 758
Other Current Liabilities
959 1,036 913 998 918 832 752 868 809 865 883
Total Noncurrent Liabilities
7,772 8,150 7,404 7,894 7,192 6,512 7,098 7,030 7,086 7,108 6,277
Long-Term Debt
5,317 5,759 5,078 5,530 5,089 4,395 5,007 5,051 4,998 5,027 4,341
Noncurrent Deferred & Payable Income Tax Liabilities
707 728 659 702 497 513 526 437 541 579 537
Noncurrent Employee Benefit Liabilities
593 711 712 722 613 596 580 554 599 580 448
Other Noncurrent Operating Liabilities
972 952 955 940 993 1,008 985 988 948 922 951
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,375 4,479 4,221 4,277 3,369 3,278 3,427 3,758 3,882 4,025 4,210
Total Preferred & Common Equity
3,941 4,052 3,965 4,038 3,175 3,152 3,307 3,650 3,775 3,915 4,109
Total Common Equity
3,941 4,052 3,965 4,038 3,175 3,152 3,307 3,650 3,775 3,915 4,109
Common Stock
1,173 1,138 1,161 1,175 1,206 1,168 1,187 1,210 1,226 1,110 1,121
Retained Earnings
9,197 9,293 9,447 9,509 8,804 8,878 9,027 9,195 9,358 9,497 9,590
Treasury Stock
-4,721 -4,666 -4,700 -4,692 -4,794 -4,723 -4,699 -4,557 -4,533 -4,425 -4,384
Accumulated Other Comprehensive Income / (Loss)
-1,708 -1,713 -1,943 -1,954 -2,041 -2,171 -2,208 -2,198 -2,276 -2,267 -2,218
Noncontrolling Interest
434 427 256 239 194 126 120 108 107 110 101

Annual Metrics And Ratios for Kellanova

This table displays calculated financial ratios and metrics derived from Kellanova's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.43% -7.24% -4.14% -0.86% 5.39% 0.23% 1.41% -14.69% 7.71% 3.71% -2.84%
EBITDA Growth
-54.43% -0.20% 21.06% 28.92% -10.94% -2.77% 13.89% -10.04% -25.57% 11.45% 32.35%
EBIT Growth
-63.60% -3.29% 34.00% 42.76% -15.53% -1.67% 18.44% -11.96% -33.43% 21.76% 46.31%
NOPAT Growth
-59.84% 9.26% 28.07% -5.95% 41.18% -28.32% 33.07% -25.53% -7.40% 16.74% 35.09%
Net Income Growth
-64.99% -3.00% 14.01% 79.14% 7.18% -27.31% 29.38% 17.72% -35.48% 0.42% 39.32%
EPS Growth
-64.57% -1.71% 14.53% 81.73% 6.98% -26.89% 29.64% 138.57% -35.57% -50.54% 181.16%
Operating Cash Flow Growth
-0.77% -5.69% -24.84% -68.29% 281.14% -23.44% 68.88% -14.35% -2.94% -0.36% 6.99%
Free Cash Flow Firm Growth
41.19% -33.45% -10.68% -106.12% 417.56% 661.57% -19.78% -53.99% 257.98% -46.51% 8.03%
Invested Capital Growth
-12.62% -6.15% -2.19% 12.52% 12.07% -7.80% -1.44% 3.22% -15.01% -2.65% 0.55%
Revenue Q/Q Growth
0.09% -2.68% -0.72% 1.08% 0.98% -0.69% 1.78% -17.42% 1.48% 18.01% -0.39%
EBITDA Q/Q Growth
-53.41% 34.44% 5.75% 30.96% -23.45% 17.99% 2.34% -11.61% -22.46% 42.10% 18.02%
EBIT Q/Q Growth
-62.15% 59.74% 7.03% 46.93% -29.62% 26.61% 2.95% -14.28% -29.61% 73.29% 21.15%
NOPAT Q/Q Growth
-57.85% 35.81% 6.67% 18.03% 2.04% -0.82% 4.40% -23.95% -2.61% 33.99% 13.97%
Net Income Q/Q Growth
-63.72% 70.08% -0.99% 58.73% -27.08% 31.49% 4.64% 17.26% -35.53% 16.71% 31.93%
EPS Q/Q Growth
-63.47% 65.38% 0.00% 59.11% -27.32% 30.84% 4.91% 136.61% -35.64% -60.46% 145.57%
Operating Cash Flow Q/Q Growth
12.41% 6.69% -27.08% -8.41% 34.86% -23.39% 7.70% 10.60% -4.90% -12.08% 14.43%
Free Cash Flow Firm Q/Q Growth
81.98% 2.12% -18.35% -110.74% 127.66% -24.48% 3.13% -14.74% 144.20% -2.76% -39.82%
Invested Capital Q/Q Growth
-8.35% -7.02% -3.54% 6.96% -4.14% 1.27% 1.41% -0.59% -15.08% -12.68% -1.22%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.73% 34.61% 37.29% 36.56% 34.89% 32.27% 34.33% 32.50% 30.12% 32.64% 35.65%
EBITDA Margin
10.54% 11.34% 14.32% 18.62% 15.74% 15.27% 17.15% 18.08% 12.50% 13.43% 18.29%
Operating Margin
7.02% 8.07% 11.44% 10.79% 12.59% 10.32% 12.79% 11.77% 9.57% 11.47% 14.69%
EBIT Margin
7.09% 7.39% 10.34% 14.88% 11.93% 11.70% 13.67% 14.11% 8.72% 10.23% 15.41%
Profit (Net Income) Margin
4.34% 4.54% 5.40% 9.76% 9.92% 7.20% 9.18% 12.67% 7.59% 7.35% 10.53%
Tax Burden Percent
76.73% 79.43% 74.95% 75.68% 101.13% 74.87% 78.95% 102.48% 106.43% 92.69% 81.20%
Interest Burden Percent
79.79% 77.30% 69.70% 86.62% 82.24% 82.13% 85.07% 87.63% 81.78% 77.44% 84.17%
Effective Tax Rate
22.55% 20.57% 25.16% 24.74% 13.62% 24.60% 20.17% 24.31% 19.96% 24.81% 18.38%
Return on Invested Capital (ROIC)
7.57% 9.14% 12.23% 10.94% 13.76% 9.71% 13.57% 10.02% 9.87% 12.71% 17.36%
ROIC Less NNEP Spread (ROIC-NNEP)
5.36% 5.53% 6.41% 13.76% 12.15% 8.67% 11.51% 16.78% 9.70% 9.38% 13.77%
Return on Net Nonoperating Assets (RNNOA)
12.04% 15.47% 22.22% 49.93% 36.45% 20.47% 22.81% 27.89% 12.48% 12.19% 19.69%
Return on Equity (ROE)
19.60% 24.61% 34.45% 60.87% 50.21% 30.19% 36.37% 37.91% 22.35% 24.90% 37.04%
Cash Return on Invested Capital (CROIC)
21.04% 15.49% 14.44% -0.84% 2.38% 17.83% 15.02% 6.85% 26.09% 15.39% 16.81%
Operating Return on Assets (OROA)
6.75% 6.58% 8.83% 12.16% 9.47% 8.99% 10.58% 9.16% 6.02% 7.87% 12.58%
Return on Assets (ROA)
4.13% 4.04% 4.61% 7.97% 7.88% 5.53% 7.11% 8.23% 5.24% 5.65% 8.60%
Return on Common Equity (ROCE)
19.23% 24.26% 34.23% 60.40% 44.83% 24.94% 30.66% 32.99% 19.93% 22.88% 35.51%
Return on Equity Simple (ROE_SIMPLE)
0.00% 28.85% 36.65% 57.58% 51.67% 35.57% 40.62% 40.00% 24.36% 30.36% 35.58%
Net Operating Profit after Tax (NOPAT)
793 867 1,110 1,044 1,474 1,056 1,406 1,047 969 1,132 1,529
NOPAT Margin
5.44% 6.41% 8.56% 8.12% 10.88% 7.78% 10.21% 8.91% 7.66% 8.62% 11.99%
Net Nonoperating Expense Percent (NNEP)
2.21% 3.62% 5.82% -2.81% 1.61% 1.04% 2.06% -6.76% 0.17% 3.33% 3.58%
Return On Investment Capital (ROIC_SIMPLE)
7.76% 8.77% 11.45% 9.66% 12.23% 9.40% 12.65% 9.24% 8.86% 12.24% 15.88%
Cost of Revenue to Revenue
65.27% 65.39% 62.72% 63.44% 65.11% 67.73% 65.67% 67.50% 69.88% 67.36% 64.35%
SG&A Expenses to Revenue
27.70% 26.54% 25.85% 25.77% 22.29% 21.95% 21.54% 20.73% 20.55% 21.17% 20.96%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
27.70% 26.54% 25.85% 25.77% 22.29% 21.95% 21.54% 20.73% 20.55% 21.17% 20.96%
Earnings before Interest and Taxes (EBIT)
1,034 1,000 1,340 1,913 1,616 1,589 1,882 1,657 1,103 1,343 1,965
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,537 1,534 1,857 2,394 2,132 2,073 2,361 2,124 1,581 1,762 2,332
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.53 8.29 9.58 7.86 5.76 6.73 5.58 4.97 5.37 5.79 7.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.06 1.30 1.41 1.33 1.11 1.36 1.26 1.58 1.67 1.40 2.18
Price to Earnings (P/E)
24.41 28.72 26.17 13.65 11.21 19.24 13.87 12.49 22.10 19.34 20.89
Dividend Yield
4.37% 3.98% 3.91% 4.28% 5.10% 4.17% 4.52% 4.26% 3.77% 4.36% 2.80%
Earnings Yield
4.10% 3.48% 3.82% 7.32% 8.92% 5.20% 7.21% 8.00% 4.53% 5.17% 4.79%
Enterprise Value to Invested Capital (EV/IC)
2.29 2.69 2.83 2.48 2.09 2.51 2.38 2.39 3.04 2.73 3.72
Enterprise Value to Revenue (EV/Rev)
1.54 1.82 1.96 1.95 1.75 1.93 1.78 2.16 2.17 1.83 2.58
Enterprise Value to EBITDA (EV/EBITDA)
14.58 16.09 13.65 10.46 11.11 12.62 10.39 11.96 17.35 13.62 14.08
Enterprise Value to EBIT (EV/EBIT)
21.68 24.68 18.92 13.09 14.66 16.46 13.03 15.33 24.87 17.87 16.71
Enterprise Value to NOPAT (EV/NOPAT)
28.26 28.48 22.85 23.99 16.07 24.77 17.45 24.26 28.30 21.21 21.48
Enterprise Value to Operating Cash Flow (EV/OCF)
12.50 14.60 19.95 62.14 15.42 22.25 12.35 14.93 16.62 14.59 18.66
Enterprise Value to Free Cash Flow (EV/FCFF)
10.16 16.82 19.34 0.00 93.02 13.49 15.77 35.48 10.71 17.51 22.18
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.59 3.62 4.03 3.93 2.82 2.39 2.06 1.69 1.50 1.74 1.48
Long-Term Debt to Equity
2.08 2.47 3.48 3.57 2.60 2.17 1.86 1.49 1.22 1.51 1.29
Financial Leverage
2.25 2.80 3.47 3.63 3.00 2.36 1.98 1.66 1.29 1.30 1.43
Leverage Ratio
4.74 6.09 7.47 7.64 6.38 5.46 5.12 4.61 4.27 4.41 4.31
Compound Leverage Factor
3.78 4.71 5.21 6.61 5.24 4.48 4.35 4.04 3.49 3.41 3.63
Debt to Total Capital
72.11% 78.37% 80.13% 79.70% 73.79% 70.51% 67.28% 62.78% 60.01% 63.55% 59.67%
Short-Term Debt to Total Capital
14.04% 24.99% 11.03% 7.21% 5.69% 6.47% 6.56% 7.50% 11.40% 8.48% 7.74%
Long-Term Debt to Total Capital
58.07% 53.37% 69.10% 72.50% 68.10% 64.04% 60.71% 55.29% 48.61% 55.06% 51.93%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.61% 0.10% 0.17% 0.15% 4.63% 5.05% 4.72% 4.37% 3.97% 2.10% 1.11%
Common Equity to Total Capital
27.29% 21.53% 19.70% 20.15% 21.58% 24.45% 28.01% 32.84% 36.03% 34.35% 39.22%
Debt to EBITDA
4.80 5.05 4.18 3.60 4.17 3.82 3.17 3.35 4.15 3.33 2.46
Net Debt to EBITDA
4.51 4.59 3.80 3.30 3.83 3.44 2.82 3.01 3.69 3.07 2.12
Long-Term Debt to EBITDA
3.86 3.44 3.61 3.27 3.85 3.47 2.86 2.95 3.36 2.89 2.14
Debt to NOPAT
9.29 8.94 7.00 8.25 6.03 7.50 5.32 6.79 6.77 5.19 3.76
Net Debt to NOPAT
8.73 8.12 6.35 7.57 5.54 6.74 4.73 6.12 6.02 4.79 3.24
Long-Term Debt to NOPAT
7.48 6.09 6.04 7.51 5.57 6.81 4.80 5.98 5.49 4.50 3.27
Altman Z-Score
2.48 2.32 2.47 2.39 2.19 2.38 2.37 2.31 2.34 2.68 3.42
Noncontrolling Interest Sharing Ratio
1.92% 1.44% 0.64% 0.78% 10.72% 17.38% 15.70% 12.98% 10.81% 8.11% 4.15%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.77 0.56 0.66 0.67 0.70 0.72 0.66 0.64 0.66 0.66 0.81
Quick Ratio
0.39 0.28 0.34 0.37 0.37 0.41 0.38 0.33 0.29 0.36 0.48
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2,205 1,468 1,311 -80 255 1,939 1,556 716 2,562 1,371 1,481
Operating Cash Flow to CapEx
308.08% 305.79% 250.69% 80.44% 265.74% 200.68% 393.27% 307.59% 338.32% 242.98% 280.25%
Free Cash Flow to Firm to Interest Expense
10.55 6.47 3.23 -0.31 0.89 6.83 5.54 3.49 12.75 4.52 4.76
Operating Cash Flow to Interest Expense
8.58 7.45 3.13 1.57 5.35 4.14 7.07 8.30 8.21 5.43 5.66
Operating Cash Flow Less CapEx to Interest Expense
5.79 5.01 1.88 -0.38 3.34 2.08 5.27 5.60 5.79 3.19 3.64
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.95 0.89 0.85 0.82 0.79 0.77 0.77 0.65 0.69 0.77 0.82
Accounts Receivable Turnover
10.80 10.32 10.07 9.81 9.80 9.20 8.85 7.76 8.38 8.47 8.25
Inventory Turnover
7.53 6.99 6.54 6.64 6.93 7.20 7.21 5.91 6.46 6.85 6.81
Fixed Asset Turnover
3.82 3.66 3.61 3.53 3.64 3.70 3.76 3.12 3.66 4.16 3.96
Accounts Payable Turnover
6.43 5.15 4.15 3.81 3.76 3.82 3.72 3.14 3.44 3.62 3.61
Days Sales Outstanding (DSO)
33.80 35.35 36.25 37.20 37.24 39.66 41.26 47.01 43.57 43.11 44.23
Days Inventory Outstanding (DIO)
48.46 52.19 55.84 54.94 52.70 50.72 50.66 61.73 56.49 53.31 53.57
Days Payable Outstanding (DPO)
56.76 70.88 88.01 95.85 97.16 95.53 98.04 116.10 106.11 100.80 101.22
Cash Conversion Cycle (CCC)
25.49 16.66 4.08 -3.71 -7.23 -5.14 -6.13 -7.35 -6.05 -4.37 -3.42
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
9,777 9,176 8,975 10,099 11,318 10,435 10,285 10,616 9,023 8,784 8,832
Invested Capital Turnover
1.39 1.43 1.43 1.35 1.27 1.25 1.33 1.12 1.29 1.47 1.45
Increase / (Decrease) in Invested Capital
-1,412 -601 -201 1,124 1,219 -883 -150 331 -1,593 -239 48
Enterprise Value (EV)
22,412 24,682 25,356 25,042 23,687 26,162 24,526 25,399 27,436 24,001 32,844
Market Capitalization
15,424 17,634 18,291 17,121 14,970 18,474 17,353 18,503 21,169 18,392 27,787
Book Value per Share
$7.86 $6.00 $5.44 $6.30 $7.50 $8.05 $9.05 $10.91 $11.55 $9.27 $10.95
Tangible Book Value per Share
($12.61) ($14.41) ($16.03) ($17.27) ($19.62) ($16.68) ($15.06) ($13.07) ($10.78) ($11.43) ($8.67)
Total Capital
10,221 9,883 9,693 10,809 12,052 11,236 11,111 11,326 10,939 9,242 9,625
Total Debt
7,370 7,745 7,767 8,615 8,893 7,922 7,475 7,111 6,564 5,873 5,743
Total Long-Term Debt
5,935 5,275 6,698 7,836 8,207 7,195 6,746 6,262 5,317 5,089 4,998
Net Debt
6,926 7,038 7,049 7,905 8,159 7,121 6,649 6,401 5,833 5,415 4,950
Capital Expenditures (CapEx)
582 553 507 501 578 586 505 553 488 677 628
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-32 -284 -745 -988 -1,007 -1,017 -1,462 -1,358 -1,215 -1,220 -855
Debt-free Net Working Capital (DFNWC)
411 -33 -465 -707 -686 -620 -1,027 -1,072 -916 -946 -161
Net Working Capital (NWC)
-1,024 -2,503 -1,534 -1,486 -1,372 -1,347 -1,756 -1,921 -2,163 -1,730 -906
Net Nonoperating Expense (NNE)
160 253 410 -210 130 79 142 -441 9.34 168 186
Net Nonoperating Obligations (NNO)
6,926 7,038 7,049 7,905 8,159 7,121 6,649 6,401 4,648 5,415 4,950
Total Depreciation and Amortization (D&A)
503 534 517 481 516 484 479 467 478 419 367
Debt-free, Cash-free Net Working Capital to Revenue
-0.22% -2.10% -5.75% -7.69% -7.43% -7.49% -10.62% -11.56% -9.60% -9.30% -6.71%
Debt-free Net Working Capital to Revenue
2.82% -0.24% -3.59% -5.50% -5.06% -4.57% -7.46% -9.13% -7.24% -7.21% -1.26%
Net Working Capital to Revenue
-7.02% -18.51% -11.83% -11.56% -10.13% -9.92% -12.75% -16.35% -17.09% -13.18% -7.11%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.76 $1.74 $1.98 $3.65 $3.85 $2.81 $3.65 $4.36 $2.81 $2.78 $7.84
Adjusted Weighted Average Basic Shares Outstanding
356.57M 350.26M 351.14M 345.75M 343.89M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Adjusted Diluted Earnings per Share
$1.75 $1.72 $1.96 $3.62 $3.83 $2.80 $3.63 $4.33 $2.79 $2.76 $7.76
Adjusted Weighted Average Diluted Shares Outstanding
356.57M 350.26M 351.14M 345.75M 343.89M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $2.81 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
356.57M 350.26M 351.14M 345.75M 343.89M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Normalized Net Operating Profit after Tax (NOPAT)
793 867 1,110 1,044 1,474 1,056 1,406 1,047 969 1,132 1,529
Normalized NOPAT Margin
5.44% 6.41% 8.56% 8.12% 10.88% 7.78% 10.21% 8.91% 7.66% 8.62% 11.99%
Pre Tax Income Margin
5.66% 5.72% 7.20% 12.89% 9.81% 9.61% 11.63% 12.36% 7.13% 7.93% 12.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.95 4.41 3.30 7.47 5.63 5.60 6.70 8.08 5.49 4.43 6.32
NOPAT to Interest Expense
3.79 3.82 2.73 4.08 5.13 3.72 5.00 5.11 4.82 3.73 4.92
EBIT Less CapEx to Interest Expense
2.16 1.97 2.05 5.52 3.62 3.53 4.90 5.39 3.06 2.20 4.30
NOPAT Less CapEx to Interest Expense
1.01 1.38 1.48 2.12 3.12 1.66 3.21 2.41 2.39 1.50 2.90
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
107.43% 114.01% 102.29% 58.69% 56.70% 78.71% 61.87% 52.96% 83.02% 82.99% 57.78%
Augmented Payout Ratio
216.43% 233.06% 163.14% 99.84% 80.51% 101.23% 61.87% 69.09% 114.27% 100.62% 57.78%

Quarterly Metrics And Ratios for Kellanova

This table displays calculated financial ratios and metrics derived from Kellanova's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
18.76% -8.99% -13.28% -17.51% 171.05% -4.25% -4.74% -0.68% -1.58% -3.66% 0.34%
EBITDA Growth
-229.00% -32.54% -6.57% -13.27% 202.33% 8.98% 11.89% 22.63% 134.85% 2.11% -13.37%
EBIT Growth
-587.34% -38.58% -6.32% -16.59% 147.53% 20.11% 18.20% 35.51% 187.43% 1.15% -15.02%
NOPAT Growth
-88.54% -32.98% 3.54% 0.18% 400.85% 10.13% 16.44% 40.35% 126.77% 15.00% -10.84%
Net Income Growth
-123.89% -28.77% 9.51% -13.78% 135.29% -10.26% -3.64% 36.43% 902.78% 13.65% -11.92%
EPS Growth
-55.28% -30.08% 116.84% 73.33% -168.80% -9.30% -2.91% 34.62% 267.44% 11.54% -15.00%
Operating Cash Flow Growth
-15.29% -15.60% -23.01% 101.60% -47.98% 31.88% 2.17% -26.85% 90.61% -68.13% -55.05%
Free Cash Flow Firm Growth
520.47% 458.64% 341.93% 145.78% -72.14% 205.84% 118.78% 78.15% -11.58% -99.59% -120.68%
Invested Capital Growth
-15.01% -3.28% -4.56% -5.32% -2.65% -15.48% -13.72% -11.12% 0.55% 3.82% 8.04%
Revenue Q/Q Growth
-70.32% 185.40% 0.27% -2.86% -2.49% 0.82% -0.25% 1.28% -3.37% -1.31% 3.89%
EBITDA Q/Q Growth
-148.22% 285.66% 15.87% -16.40% -43.10% 97.73% 18.97% -8.37% 8.96% -14.03% 0.94%
EBIT Q/Q Growth
-191.23% 194.29% 22.59% -20.90% -48.01% 138.25% 20.64% -9.32% 10.27% -16.16% 1.36%
NOPAT Q/Q Growth
-120.98% 539.75% 20.70% -10.06% -36.98% 60.97% 27.62% 8.41% 1.82% -18.37% -1.05%
Net Income Q/Q Growth
-132.69% 396.08% 18.21% -24.65% -86.62% 652.78% 26.94% 6.69% -1.63% -14.68% -1.62%
EPS Q/Q Growth
177.78% -65.60% 139.53% -24.27% -210.26% 145.35% 156.41% 5.00% 37.14% -69.79% -2.30%
Operating Cash Flow Q/Q Growth
25.60% -41.40% 33.33% 105.43% -67.59% 48.57% 3.30% 47.07% -15.55% -75.16% 45.69%
Free Cash Flow Firm Q/Q Growth
336.22% -58.84% 30.75% 4.70% -50.55% 351.82% -6.47% -14.74% -75.46% -97.89% -4,783.18%
Invested Capital Q/Q Growth
-15.08% 16.31% -1.59% -2.59% -12.68% 0.98% 0.46% 0.34% -1.22% 4.27% 4.54%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
30.40% 29.44% 32.65% 34.10% 34.50% 32.22% 36.37% 36.37% 37.68% 34.35% 34.03%
EBITDA Margin
-22.03% 14.33% 16.56% 14.26% 8.32% 16.31% 19.45% 17.60% 19.85% 17.29% 16.80%
Operating Margin
-7.60% 10.35% 12.44% 12.72% 10.33% 12.28% 15.44% 14.10% 17.00% 13.95% 13.67%
EBIT Margin
-32.88% 10.86% 13.28% 10.81% 5.77% 13.63% 16.48% 14.75% 16.84% 14.30% 13.96%
Profit (Net Income) Margin
-8.71% 9.04% 10.65% 8.26% 1.13% 8.47% 10.78% 11.35% 11.56% 9.99% 9.46%
Tax Burden Percent
23.34% 103.07% 95.97% 97.11% 36.73% 76.77% 77.65% 91.29% 79.17% 81.48% 78.91%
Interest Burden Percent
113.51% 80.72% 83.60% 78.69% 53.55% 80.96% 84.22% 84.28% 86.69% 85.71% 85.91%
Effective Tax Rate
0.00% 20.82% 20.70% 28.16% 42.86% 23.23% 21.90% 8.46% 19.96% 19.31% 21.61%
Return on Invested Capital (ROIC)
-6.86% 9.47% 11.02% 9.82% 8.70% 12.64% 16.08% 17.39% 19.69% 15.73% 14.62%
ROIC Less NNEP Spread (ROIC-NNEP)
-7.57% 9.91% 11.45% 9.34% 5.69% 12.11% 15.37% 16.47% 18.46% 15.00% 13.88%
Return on Net Nonoperating Assets (RNNOA)
-9.74% 14.20% 16.13% 12.09% 7.40% 18.12% 23.29% 22.48% 26.38% 22.14% 19.81%
Return on Equity (ROE)
-16.60% 23.67% 27.15% 21.91% 16.10% 30.76% 39.37% 39.88% 46.08% 37.86% 34.43%
Cash Return on Invested Capital (CROIC)
26.09% 11.18% 12.76% 13.63% 15.39% 28.75% 27.33% 25.90% 16.81% 13.67% 8.82%
Operating Return on Assets (OROA)
-22.69% 7.19% 8.47% 6.38% 4.44% 10.42% 12.65% 10.96% 13.74% 11.74% 11.32%
Return on Assets (ROA)
-6.01% 5.98% 6.79% 4.87% 0.87% 6.48% 8.27% 8.43% 9.43% 8.20% 7.67%
Return on Common Equity (ROCE)
-14.80% 21.17% 24.89% 20.22% 14.80% 28.57% 37.44% 38.16% 44.16% 36.64% 33.44%
Return on Equity Simple (ROE_SIMPLE)
0.00% 20.68% 21.92% 20.46% 0.00% 29.60% 27.82% 27.89% 0.00% 35.25% 0.00%
Net Operating Profit after Tax (NOPAT)
-62 274 331 297 187 302 385 417 425 347 343
NOPAT Margin
-5.32% 8.20% 9.87% 9.14% 5.91% 9.43% 12.06% 12.91% 13.61% 11.25% 10.72%
Net Nonoperating Expense Percent (NNEP)
0.72% -0.45% -0.43% 0.49% 3.01% 0.53% 0.71% 0.92% 1.24% 0.72% 0.74%
Return On Investment Capital (ROIC_SIMPLE)
-0.57% 2.43% 3.02% 2.62% 2.03% 3.28% 4.14% 4.34% 4.42% 3.60% 3.40%
Cost of Revenue to Revenue
69.60% 70.56% 67.35% 65.90% 65.50% 67.78% 63.63% 63.63% 62.32% 65.65% 65.97%
SG&A Expenses to Revenue
38.00% 19.09% 20.20% 21.38% 24.17% 19.94% 20.93% 22.27% 20.68% 20.40% 20.36%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
38.00% 19.09% 20.20% 21.38% 24.17% 19.94% 20.93% 22.27% 20.68% 20.40% 20.36%
Earnings before Interest and Taxes (EBIT)
-385 363 445 352 183 436 526 477 526 441 447
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-258 479 555 464 264 522 621 569 620 533 538
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.37 4.96 5.16 4.52 5.79 6.04 5.84 7.47 7.36 7.27 6.67
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.67 1.63 1.73 1.64 1.40 1.47 1.51 2.13 2.18 2.25 2.17
Price to Earnings (P/E)
22.10 24.11 23.81 22.29 19.34 20.69 21.24 27.13 20.89 20.83 20.69
Dividend Yield
3.77% 4.00% 3.95% 4.45% 4.36% 4.16% 4.04% 2.82% 2.80% 2.75% 2.89%
Earnings Yield
4.53% 4.15% 4.20% 4.49% 5.17% 4.83% 4.71% 3.69% 4.79% 4.80% 4.83%
Enterprise Value to Invested Capital (EV/IC)
3.04 2.53 2.60 2.41 2.73 2.79 2.80 3.64 3.72 3.67 3.42
Enterprise Value to Revenue (EV/Rev)
2.17 2.15 2.27 2.18 1.83 1.91 1.94 2.54 2.58 2.67 2.60
Enterprise Value to EBITDA (EV/EBITDA)
17.35 19.66 20.47 19.56 13.62 13.71 13.32 16.48 14.08 14.41 14.57
Enterprise Value to EBIT (EV/EBIT)
24.87 30.34 31.76 31.30 17.87 17.48 16.64 20.07 16.71 17.14 17.41
Enterprise Value to NOPAT (EV/NOPAT)
28.30 31.73 31.35 28.72 21.21 21.37 20.55 24.27 21.48 21.45 21.47
Enterprise Value to Operating Cash Flow (EV/OCF)
16.62 16.59 18.01 12.96 14.59 14.28 14.31 21.17 18.66 22.33 25.23
Enterprise Value to Free Cash Flow (EV/FCFF)
10.71 22.26 19.89 17.21 17.51 8.89 9.48 13.23 22.18 27.33 40.29
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.50 1.52 1.60 1.65 1.74 1.81 1.71 1.56 1.48 1.40 1.40
Long-Term Debt to Equity
1.22 1.29 1.20 1.29 1.51 1.34 1.46 1.34 1.29 1.25 1.03
Financial Leverage
1.29 1.43 1.41 1.29 1.30 1.50 1.52 1.36 1.43 1.48 1.43
Leverage Ratio
4.27 4.24 4.22 4.18 4.41 4.38 4.37 4.29 4.31 4.22 4.08
Compound Leverage Factor
4.85 3.43 3.53 3.29 2.36 3.54 3.68 3.61 3.74 3.61 3.51
Debt to Total Capital
60.01% 60.28% 61.48% 62.33% 63.55% 64.42% 63.11% 60.90% 59.67% 58.26% 58.27%
Short-Term Debt to Total Capital
11.40% 9.21% 15.15% 13.62% 8.48% 16.71% 9.21% 8.34% 7.74% 6.12% 15.24%
Long-Term Debt to Total Capital
48.61% 51.07% 46.34% 48.71% 55.06% 47.71% 53.90% 52.55% 51.93% 52.14% 43.03%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.97% 3.79% 2.34% 2.11% 2.10% 1.37% 1.29% 1.12% 1.11% 1.14% 1.00%
Common Equity to Total Capital
36.03% 35.93% 36.18% 35.57% 34.35% 34.22% 35.60% 37.98% 39.22% 40.60% 40.73%
Debt to EBITDA
4.15 5.03 5.14 5.71 3.33 3.29 3.13 2.96 2.46 2.40 2.60
Net Debt to EBITDA
3.69 4.46 4.66 4.66 3.07 3.10 2.93 2.62 2.12 2.21 2.40
Long-Term Debt to EBITDA
3.36 4.27 3.87 4.46 2.89 2.43 2.68 2.56 2.14 2.15 1.92
Debt to NOPAT
6.77 8.12 7.87 8.38 5.19 5.12 4.84 4.36 3.76 3.57 3.83
Net Debt to NOPAT
6.02 7.19 7.13 6.85 4.79 4.83 4.52 3.86 3.24 3.29 3.53
Long-Term Debt to NOPAT
5.49 6.88 5.93 6.55 4.50 3.79 4.13 3.77 3.27 3.19 2.83
Altman Z-Score
2.07 2.17 2.20 2.03 2.44 2.54 2.65 3.01 3.12 3.19 3.02
Noncontrolling Interest Sharing Ratio
10.81% 10.57% 8.34% 7.70% 8.11% 7.13% 4.92% 4.32% 4.15% 3.23% 2.89%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.66 0.72 0.66 0.76 0.66 0.62 0.73 0.77 0.81 0.80 0.68
Quick Ratio
0.29 0.36 0.35 0.46 0.36 0.35 0.40 0.46 0.48 0.44 0.38
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,531 630 824 862 426 1,927 1,802 1,536 377 7.96 -373
Operating Cash Flow to CapEx
341.30% 135.96% 270.59% 452.69% 143.27% 234.84% 264.79% 386.71% 248.40% 65.91% 114.19%
Free Cash Flow to Firm to Interest Expense
29.44 9.00 11.28 11.50 5.02 23.21 21.71 20.49 5.39 0.13 -5.92
Operating Cash Flow to Interest Expense
9.06 3.94 5.04 10.08 2.88 4.39 4.53 7.37 6.67 1.84 2.68
Operating Cash Flow Less CapEx to Interest Expense
6.40 1.04 3.18 7.85 0.87 2.52 2.82 5.47 3.99 -0.95 0.33
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.69 0.66 0.64 0.59 0.77 0.76 0.77 0.74 0.82 0.82 0.81
Accounts Receivable Turnover
8.38 7.03 6.19 5.76 8.47 7.45 7.15 7.16 8.25 7.80 7.54
Inventory Turnover
6.46 5.17 4.86 4.57 6.85 5.75 5.83 5.85 6.81 6.62 6.67
Fixed Asset Turnover
3.66 3.26 3.18 3.04 4.16 3.77 3.72 3.67 3.96 3.92 3.82
Accounts Payable Turnover
3.44 3.10 2.90 2.68 3.62 3.39 3.32 3.23 3.61 3.72 3.64
Days Sales Outstanding (DSO)
43.57 51.94 58.94 63.37 43.11 49.01 51.02 50.98 44.23 46.78 48.39
Days Inventory Outstanding (DIO)
56.49 70.59 75.10 79.84 53.31 63.53 62.63 62.42 53.57 55.10 54.72
Days Payable Outstanding (DPO)
106.11 117.75 125.97 136.36 100.80 107.79 109.99 112.90 101.22 98.24 100.25
Cash Conversion Cycle (CCC)
-6.05 4.77 8.07 6.85 -4.37 4.75 3.66 0.49 -3.42 3.64 2.86
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
9,023 10,495 10,328 10,060 8,784 8,870 8,911 8,941 8,832 9,209 9,627
Invested Capital Turnover
1.29 1.15 1.12 1.08 1.47 1.34 1.33 1.35 1.45 1.40 1.36
Increase / (Decrease) in Invested Capital
-1,593 -356 -493 -565 -239 -1,625 -1,417 -1,119 48 339 716
Enterprise Value (EV)
27,436 26,548 26,837 24,254 24,001 24,754 24,913 32,558 32,844 33,764 32,926
Market Capitalization
21,169 20,105 20,474 18,232 18,392 19,036 19,309 27,267 27,787 28,470 27,408
Book Value per Share
$11.55 $11.85 $11.57 $11.80 $9.27 $9.24 $9.67 $10.66 $10.95 $11.32 $11.84
Tangible Book Value per Share
($10.78) ($11.51) ($10.63) ($10.29) ($11.43) ($10.98) ($10.35) ($9.33) ($8.67) ($8.32) ($7.97)
Total Capital
10,939 11,276 10,959 11,353 9,242 9,212 9,290 9,611 9,625 9,642 10,089
Total Debt
6,564 6,797 6,738 7,076 5,873 5,934 5,863 5,853 5,743 5,617 5,879
Total Long-Term Debt
5,317 5,759 5,078 5,530 5,089 4,395 5,007 5,051 4,998 5,027 4,341
Net Debt
5,833 6,016 6,107 5,783 5,415 5,592 5,484 5,183 4,950 5,184 5,417
Capital Expenditures (CapEx)
138 203 136 167 171 155 142 143 188 176 148
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,215 -986 -836 -1,091 -1,220 -778 -720 -887 -855 -607 -527
Debt-free Net Working Capital (DFNWC)
-916 -639 -528 8.00 -946 -536 -448 -318 -161 -277 -173
Net Working Capital (NWC)
-2,163 -1,677 -2,188 -1,538 -1,730 -2,075 -1,304 -1,120 -906 -867 -1,711
Net Nonoperating Expense (NNE)
40 -28 -26 28 151 31 41 50 64 39 40
Net Nonoperating Obligations (NNO)
4,648 6,016 6,107 5,783 5,415 5,592 5,484 5,183 4,950 5,184 5,417
Total Depreciation and Amortization (D&A)
127 116 110 112 81 86 95 92 94 92 91
Debt-free, Cash-free Net Working Capital to Revenue
-9.60% -8.00% -7.08% -9.81% -9.30% -5.99% -5.62% -6.93% -6.71% -4.81% -4.17%
Debt-free Net Working Capital to Revenue
-7.24% -5.19% -4.47% 0.07% -7.21% -4.13% -3.49% -2.48% -1.26% -2.19% -1.37%
Net Working Capital to Revenue
-17.09% -13.61% -18.53% -13.83% -13.18% -15.99% -10.17% -8.75% -7.11% -6.86% -13.53%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.51 $0.87 $1.04 $0.79 ($1.75) $0.78 $2.02 $2.14 $2.90 $0.88 $0.86
Adjusted Weighted Average Basic Shares Outstanding
341.83M 342M 343M 342M 340.68M 341M 342M 343M 345.22M 346M 347M
Adjusted Diluted Earnings per Share
$2.50 $0.86 $1.03 $0.78 ($1.72) $0.78 $2.00 $2.10 $2.88 $0.87 $0.85
Adjusted Weighted Average Diluted Shares Outstanding
341.83M 345M 345M 345M 340.68M 344M 345M 347M 345.22M 349M 350M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
341.83M 342.76M 342.35M 342.52M 340.68M 341.88M 342.29M 344.70M 345.22M 346.94M 347.67M
Normalized Net Operating Profit after Tax (NOPAT)
-62 274 331 297 187 302 385 417 425 347 343
Normalized NOPAT Margin
-5.32% 8.20% 9.87% 9.14% 5.91% 9.43% 12.06% 12.91% 13.61% 11.25% 10.72%
Pre Tax Income Margin
-37.32% 8.77% 11.10% 8.51% 3.09% 11.03% 13.88% 12.43% 14.60% 12.26% 11.99%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-7.40 5.19 6.10 4.69 2.15 5.25 6.34 6.36 7.51 7.00 7.10
NOPAT to Interest Expense
-1.20 3.91 4.53 3.97 2.21 3.64 4.64 5.57 6.07 5.51 5.45
EBIT Less CapEx to Interest Expense
-10.06 2.29 4.23 2.47 0.14 3.39 4.63 4.45 4.83 4.21 4.75
NOPAT Less CapEx to Interest Expense
-3.85 1.01 2.67 1.74 0.19 1.77 2.93 3.66 3.39 2.71 3.10
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
83.02% 95.70% 92.87% 98.18% 82.99% 84.57% 84.67% 75.64% 57.78% 56.67% 58.85%
Augmented Payout Ratio
114.27% 95.70% 99.77% 105.45% 100.62% 102.79% 96.63% 86.44% 57.78% 56.67% 58.85%

Key Financial Trends

Analyzing Kellanova's financial statements covering Q2 2022 through Q2 2025 reveals several key trends in revenue, profitability, cash flow, and balance sheet strength.

  • Revenue Growth: Operating revenues increased from approximately $3.35B in Q2 2023 to $3.20B in Q2 2025, showing stability and a slight increase quarter-over-quarter despite some fluctuations.
  • Consistent Profitability: Net income attributable to common shareholders remained positive in recent years, showing improvement from a net loss in 2022 Q4 (-$100M) to solid profits around $299M in Q2 2025.
  • Strong Gross Profit Margins: Gross profit remained healthy, close to $1.09B in Q2 2025 (about 34% margin), supporting operational efficiency.
  • Stable Dividend Payments: Dividends per share stayed consistent at around $0.57–$0.60, reflecting commitment to returning cash to shareholders.
  • Steady Share Count: Weighted average diluted shares outstanding remain stable (~345 million), indicating limited dilution over the periods.
  • Improved Operating Cash Flow: Net cash from operating activities increased from $364M in Q2 2023 to $169M in Q2 2025 (note here Q1 2025 operating cash flow was $116M and Q2 2025 $169M), indicating strong cash-generating ability.
  • Capital Investments Continuation: Regular investments in property, plant, and equipment in the range of $130–$200M per quarter demonstrate ongoing investment in business infrastructure.
  • Debt Reduction Efforts: The company has consistently repaid significant portions of debt, including repayments of $184M in Q2 2025 and sizable repayments in prior quarters, moderately strengthening the balance sheet.
  • Stable Total Assets: Total assets fluctuated around $15.3B–$18.7B across quarters, showing stable asset base.
  • Current and Noncurrent Liabilities Remain Elevated: Total liabilities remain high, around $11.6B–$14.4B, indicating continued leverage and obligations on the balance sheet.
  • Goodwill and Intangible Assets: Large goodwill ($5B range) and intangible assets ($1.8B–$2.3B range) compose significant non-current assets, typical for a company with acquisitions or brand value.
  • Cash and Equivalents Fluctuate: Cash balances vary between $240M and $694M, which is modest relative to assets and liabilities.
  • Q4 2022 Loss Impact: The company reported a net loss of $100M in Q4 2022, impacted by a large $296M negative other income/expense, indicating a tough quarter historically.
  • High Operating Costs: Operating cost of revenue remains high (~$2.1B to $2.3B), which pressures margins and profit despite strong revenues.
  • Elevated Interest Expense: Interest expenses range around $60M–$85M per quarter, reflecting debt servicing costs that reduce net income.
  • Increasing Debt Levels in Prior Periods: While recent periods show repayments, earlier periods (2022-2023) indicated increased or high long-term debt near $5B, which could be a leverage risk if cash flows weaken.
  • Declining Cash Flows in some Quarters: Some quarters (e.g., Q4 2023) experienced negative net cash flow from operating or overall activities, suggesting temporary liquidity challenges.

Summary: Kellanova demonstrates solid revenue and profit growth, improved cash flow, consistent dividend payments, and ongoing investment in their business. The company has been reducing debt in recent quarters, which strengthens their financial health. However, high operating costs and debt servicing expenses remain concerns, along with volatility in cash flow during some past quarters. Investors should watch for sustained margin improvement and continued debt reduction as key positives supporting the stock going forward.

08/09/25 12:40 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Kellanova's Financials

When does Kellanova's financial year end?

According to the most recent income statement we have on file, Kellanova's fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has Kellanova's net income changed over the last 10 years?

Kellanova's net income appears to be on an upward trend, with a most recent value of $1.34 billion in 2024, rising from $633 million in 2014. The previous period was $964 million in 2023. Check out Kellanova's forecast to explore projected trends and price targets.

What is Kellanova's operating income?
Kellanova's total operating income in 2024 was $1.87 billion, based on the following breakdown:
  • Total Gross Profit: $4.55 billion
  • Total Operating Expenses: $2.67 billion
How has Kellanova's revenue changed over the last 10 years?

Over the last 10 years, Kellanova's total revenue changed from $14.58 billion in 2014 to $12.75 billion in 2024, a change of -12.6%.

How much debt does Kellanova have?

Kellanova's total liabilities were at $11.75 billion at the end of 2024, a 4.1% decrease from 2023, and a 4.5% decrease since 2014.

How much cash does Kellanova have?

In the past 10 years, Kellanova's cash and equivalents has ranged from $251 million in 2015 to $694 million in 2024, and is currently $694 million as of their latest financial filing in 2024.

How has Kellanova's book value per share changed over the last 10 years?

Over the last 10 years, Kellanova's book value per share changed from 7.86 in 2014 to 10.95 in 2024, a change of 39.4%.



This page (NYSE:K) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners